A new COVID variant is spreading rapidly and could soon become the dominant variant around the globe. The variant, called XEC, was first detected in Germany in August and appears to have a growth ...
GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...